[ad_1]
Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) posted its quarterly earnings data on Thursday. The software maker reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.03), MarketWatch Earnings reports. Allscripts Healthcare Solutions had a return on equity of 10.86% and a net margin of 11.60%. The firm had revenue of $142.70 million during the quarter, compared to the consensus estimate of $139.67 million. During the same period in the prior year, the firm posted $0.13 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis.
Shares of Allscripts Healthcare Solutions stock traded down $1.23 on Friday, reaching $18.64. 2,273,212 shares of the company were exchanged, compared to its average volume of 1,173,962. The stock has a fifty day moving average price of $21.70 and a 200-day moving average price of $19.16. The firm has a market capitalization of $2.15 billion, a price-to-earnings ratio of 16.64, a price-to-earnings-growth ratio of 1.78 and a beta of 0.98. The company has a current ratio of 1.39, a quick ratio of 1.39 and a debt-to-equity ratio of 0.25. Allscripts Healthcare Solutions has a fifty-two week low of $13.05 and a fifty-two week high of $23.25.
In other news, CFO Richard J. Poulton sold 10,000 shares of Allscripts Healthcare Solutions stock in a transaction on Tuesday, February 15th. The stock was sold at an average price of $20.83, for a total transaction of $208,300.00. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Paul Black sold 60,000 shares of Allscripts Healthcare Solutions stock in a transaction on Thursday, March 10th. The shares were sold at an average price of $21.87, for a total value of $1,312,200.00. The disclosure for this sale can be found here. 1.91% of the stock is owned by insiders.
Several hedge funds have recently modified their holdings of the company. Vident Investment Advisory LLC grew its stake in Allscripts Healthcare Solutions by 4.0% in the fourth quarter. Vident Investment Advisory LLC now owns 112,737 shares of the software maker’s stock valued at $2,080,000 after purchasing an additional 4,382 shares in the last quarter. Janus Henderson Group PLC purchased a new position in Allscripts Healthcare Solutions in the third quarter valued at about $213,000. Parametric Portfolio Associates LLC grew its stake in Allscripts Healthcare Solutions by 10.5% in the fourth quarter. Parametric Portfolio Associates LLC now owns 415,207 shares of the software maker’s stock valued at $7,661,000 after purchasing an additional 39,354 shares in the last quarter. Credit Suisse AG grew its stake in Allscripts Healthcare Solutions by 35.9% in the fourth quarter. Credit Suisse AG now owns 172,209 shares of the software maker’s stock valued at $3,178,000 after purchasing an additional 45,508 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in Allscripts Healthcare Solutions by 15.9% in the fourth quarter. Goldman Sachs Group Inc. now owns 3,427,095 shares of the software maker’s stock valued at $63,229,000 after purchasing an additional 469,894 shares in the last quarter.
A number of research firms have recently commented on MDRX. Deutsche Bank Aktiengesellschaft raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $20.00 to $26.00 in a research note on Friday, March 4th. TheStreet raised Allscripts Healthcare Solutions from a “c+” rating to a “b” rating in a research note on Friday, February 25th. Piper Sandler dropped their price objective on Allscripts Healthcare Solutions from $22.00 to $19.00 in a research note on Friday. StockNews.com downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Monday, May 2nd. Finally, Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $23.00 price objective on the stock. in a research note on Tuesday, March 29th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $22.00.
About Allscripts Healthcare Solutions (Get Rating)
Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
Receive News & Ratings for Allscripts Healthcare Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.
[ad_2]
Source link
